Dr. Gaurav Marwaha, MD

Dr. Marwaha practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Marwaha's NPI, 1669798062, was assigned on April 12, 2010. Dr. Marwaha graduated from University Of Cincinnati College Of Medicine in 2010. Dr. Marwaha holds Illinois license 036-137595.

Dr. Marwaha's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Marwaha's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Marwaha is also affiliated with Rush Oak Park Hospital. The medical group on file is Rush University Internists. Dmand AI also links Dr. Marwaha to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marwaha practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Marwaha's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Marwaha is board certified in dabr® (diplomate, american board of radiology) in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Marwaha's licenses on file in 2 states: Illinois and Ohio.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, head & neck cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Marwaha treats.

CMS data shows 1,541 Medicare services from Dr. Marwaha across 15 procedure codes in 2024, for 173 Medicare patients. Medicare paid $129,762 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 173 Medicare patients who saw Dr. Marwaha in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have cancer, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marwaha's median patient age at 75, with 52% women.

In 2024, Dr. Marwaha wrote 52 Medicare Part D claims for 26 patients. 87% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $173 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

Dr. Marwaha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marwaha as offering telehealth.

Dmand AI links 24 papers to Dr. Marwaha, published from 2012 to 2025. 2016 was the busiest year, with 4. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Radiation Oncology. Dr. Marwaha has published most often in Int J Radiat Oncol Biol Phys. Dr. Marwaha's most frequent co-authors are Kevin Lee Stephans, MD, Mary J. Fidler, MD and Jacob Y. Shin, MD.

Dmand AI links Dr. Marwaha to 9 clinical trials, 4 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Lung Neoplasms. NRG Oncology sponsors the most, 3.

CMS Open Payments shows 20 general payments to Dr. Marwaha from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. AstraZeneca Pharmaceuticals LP paid the most, $5,656.

Dmand AI lists 2 awards for Dr. Marwaha, most recently Excellence in Teaching in 2015.

Dr. Marwaha graduated from University Of Cincinnati College Of Medicine in 2010.

Dr. Marwaha is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.